RXRX - Recursion Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RXRX is currently covered by 3 analysts with an average price target of $6.29. This is a potential upside of $2.26 (56.08%) from yesterday's end of day stock price of $4.03.

Recursion Pharmaceuticals's activity chart (see below) currently has 87 price targets and 70 ratings on display. The stock rating distribution of RXRX is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.63% with an average time for these price targets to be met of 40.79 days.

Highest price target for RXRX is $8, Lowest price target is $5, average price target is $6.29.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 19-Oct-2026. First documented stock forecast 11-May-2021.

Best performing analysts who are covering RXRX - Recursion Pharmaceuticals:

Gil Blum Eric Joseph Michael Ryskin Mani Foroohar Gavin Scott Scott Schoenhaus Salveen Richter

Currently out of the existing stock ratings of RXRX, 3 are a HOLD (50%), 3 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Mar-2023

$8

$3.97 (98.51%)

$8

12 days ago
(19-Oct-2026)

2/28 (7.14%)

$4.39 (121.61%)

71

Hold Since 18-Aug-2025

$5.5

$1.47 (36.48%)

$5

5 months 17 days ago
(14-May-2026)

1/3 (33.33%)

$2.46 (80.92%)

2

Hold Since 03-Sep-2024

$5.5

$1.98 (56.25%)

$5

5 months 18 days ago
(14-May-2026)

3/6 (50%)

$2.46 (80.92%)

65

Hold Since 26-Feb-2026

$6

$1.97 (48.88%)

$10

8 months 5 days ago
(26-Feb-2026)

2/3 (66.67%)

$2.23 (59.15%)

73

Hold Since 11-May-2021

$10

10 months 15 days ago
(17-Dec-2025)

2/2 (100%)

$4.17 (71.53%)

35

Show more analysts

Please expand the browser size to see the chart

What is RXRX (Recursion Pharmaceuticals) average time for price targets to be met?

On average it took 41 days for the stock forecasts to be reached, with an average price target met ratio of 60.63%.

Which analyst most recently updated their price target on RXRX (Recursion Pharmaceuticals)?

Gil Blum

Which analyst has the most public recommendations on RXRX (Recursion Pharmaceuticals)?

Gil Blum works at NEEDHAM and has 35 price targets and 33 ratings on RXRX

Which analyst is the currently most bullish on RXRX (Recursion Pharmaceuticals)?

Donald Hooker with the highest potential upside of $32.72

Which analyst is the currently most reserved on RXRX (Recursion Pharmaceuticals)?

Eric Joseph with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?